NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

筆針頭的全球市場 (∼2026年):各類型 (標準型、安全)、長度 (4mm、5mm、6mm、8mm、10mm、12mm)、治療 (胰島素、GLP-1、生長激素)、購買區分(零售、非零售)、地區

Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1015128
出版日期 內容資訊 英文 217 Pages
訂單完成後即時交付
價格
筆針頭的全球市場 (∼2026年):各類型 (標準型、安全)、長度 (4mm、5mm、6mm、8mm、10mm、12mm)、治療 (胰島素、GLP-1、生長激素)、購買區分(零售、非零售)、地區 Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2026
出版日期: 2021年06月17日內容資訊: 英文 217 Pages
簡介

筆針頭的市場規模在預測期間內預計以11.2%的年複合成長率發展,從2021年的13億美元,成長到2026年22億美元的規模。

慢性疾病的盛行率增加,在部分國家的有利的償付方案等要素促進該市場的成長。同時,在藥物輸送中替代途的徑偏好趨勢,新興各國的償付不足,針的擔憂等課題預計抑制市場進一步成長。

各產品類型中,標準類型的筆針頭在預測期間內預計保持最大的佔有率。各長度中,預計8mm的部門保持在預測期間內最大的佔有率。

本報告提供全球筆針頭的市場調查,市場定義和概要,價值鏈,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律制度,技術、專利趨勢,市場規模的變化、預測,各類型、長度、治療、購買區分、地區/主要國家的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 價格分析
  • 價值鏈分析
  • 生態系統地圖
  • 波特的五力分析
  • 供應鏈分析
  • 法規分析
  • COVID-19的影響
  • 專利分析
  • 技術分析

第6章 市場分析、預測:各類型

  • 標準型筆針頭
  • 安全筆針頭

第7章 市場分析、預測:各長度

  • 8mm
  • 5mm
  • 6mm
  • 4mm
  • 12mm
  • 10mm

第8章 市場分析、預測:各治療

  • 胰島素療法
  • GLP-1療法
  • 生長激素療法
  • 其他

第9章 市場分析、預測:各購買種類

  • 零售
  • 非零售

第10章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第11章 競爭情形

  • 概要
  • 主要企業的策略
  • 主要企業的收益佔有率分析
  • 市場佔有率分析
  • 企業評估象限
  • 新興企業的評估象限
  • 企業的產品足跡
  • 企業的地理足跡
  • 競爭分析
  • 競爭模式

第12章 企業簡介

  • 主要企業
    • BECTON, DICKINSON AND COMPANY
    • NOVO NORDISK A/S
    • YPSOMED HOLDING AG
    • B. BRAUN MELSUNGEN AG
    • TERUMO CORPORATION
    • NIPRO CORPORATION
    • OWEN MUMFORD
    • ARKRAY
    • ULTIMED
    • HINDUSTAN SYRINGES AND MEDICAL DEVICES
    • MONTMED
    • HTL-STREFA
    • ALLISON MEDICAL, INC.
    • GLUCORX
    • BERPU MEDICAL TECHNOLOGY
    • ADVACARE PHARMA
    • ARTSANA GROUP
    • PROMISEMED DIABETES CARE
    • TRIVIDIA HEALTH
    • VOGT MEDICAL VERTRIEB
  • 其他的主要企業
    • VAN HEEK MEDICAL
    • SIMPLE DIAGNOSTICS
    • IYON
    • LINKS MEDICAL PRODUCTS
    • MHC MEDICAL PRODUCTS

第13章 附錄

目錄
Product Code: MD 2851

The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug delivery, poor reimbursement in developing countries, and needle anxiety are expected to restrain the overall market growth. The growing preference for biosimilar drugs and emerging markets are areas of opportunity in the market. The challenges faced by the market are reuse of pen needles and misuse of injection pens.

Based on product type, the standard pen needles segment holds the largest market share during the forecast period.

Based on type, the pen needles market is segmented into standard and safety pen needles. In 2020, the standard pen needles segment accounted for the largest share in the pen needles market. Standard pen needles are preferred over safety pen needles as they are more affordable, especially considering the need for daily insulin intake. The low cost of standard pen needles has also led to their wide adoption in emerging economies such as China, India, and Brazil, where the use of safety pen needles is low to negligible.

Based on length, the 8mm segment grows at the highest market share during the forecast period.

Based on length, the market is segmented into 4mm (5/32''), 5mm (3/16''), 6mm (1/4''), 8mm (5/16''), 10mm, and 12mm (1/2''). In 2020, the 8mm segment accounted for the largest share in the pen needles market. The large share of this segment is mainly attributed to the wide adoption of these needles among diabetes patients.

Based on mode of purchase, the retail segment is expected to register the highest CAGR during the forecast period.

Based on the mode of purchase, the market is categorized into retail and non-retail. The retail segment accounted for the largest share and highest growth during the forecast period. The significant discounts offered on online/retail purchases of pen needles, high convenience, increasing awareness on pen needles, and the favorable reimbursement scenario in North America and Europe are some of the key factors driving the growth of the retail segment.

Based on therapy, the insulin therapy segment is expected to register the highest CAGR during the forecast period.

Based on therapy, the market is categorized into insulin therapy, glucagon-like peptide-1 (GLP-1) therapy, growth hormone therapy, and other therapies (osteoporosis, thyroid, obesity). In 2020, insulin therapy held maximum of the global pen needles market, primarily due to the high and growing diabetic population globally. This segment is also expected to grow at the highest rate during the forecast period.

North America is expected to account for the largest share of the pen needles market in 2020

Geographically, the pen needles market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the pen needles market in 2020. The growing diabetes prevalence and favorable reimbursement scenario for pen needles, federal initiatives to create awareness about injection techniques, increasing market penetration by leading players, and the development of improved pen needle technologies are driving market growth in the US.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-60%, Tier 2-30%, and Tier 3-10%
  • By Designation - C-level-30%, Director-level-50%, Others-20%
  • By Region - North America-45%, Europe-15%, Asia Pacific-25%, Latin America- 10%, Middle East and Africa-5%

Key players in the Pen Needles Market

The key players in the pen needles market include Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), Owen Mumford (UK), Terumo Corporation (Japan), Nipro Corporation (Japan) Allison Medical (US), AdvaCare Pharma (US), Berpu Medical Technology (China), ARKRAY (Japan), GlucoRx (UK), HTL-STREFA (Poland), UltiMed, (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Diabetes Care (Canada), Montmed (Canada), Trividia Health (US), VOGT Medical Vertrieb (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), Iyon (Turkey), Links Medical Products (US), and MHC Medical Products (US).

Research Coverage:

The report analyzes the pen needles market and aims at estimating the market size and future growth potential of this market based on various segments such as type, length, therapy, mode of purchase, and region. The report also includes a product portfolio matrix of various pen needles available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global pen needles market. The report analyzes this market by type, therapy, length, and mode of purchase
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global pen needles market
  • Market Development: Comprehensive information on the lucrative emerging markets by type, therapy, length, and mode of purchase
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global pen needles market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global pen needles market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
    • 1.3.1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (PEN NEEDLES MARKET)
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY (2020)
    • FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PEN NEEDLES MARKET (2020)
    • FIGURE 8 DEMAND-SIDE ANALYSIS
    • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PEN NEEDLES MARKET (2021-2026)
    • FIGURE 11 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: PEN NEEDLES MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 13 PEN NEEDLES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 PEN NEEDLES MARKET, BY LENGTH, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 PEN NEEDLES MARKET, BY THERAPY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 GEOGRAPHIC SNAPSHOT: PEN NEEDLES MARKET

4 PREMIUM INSIGHTS

  • 4.1 PEN NEEDLES MARKET OVERVIEW
    • FIGURE 18 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET
  • 4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY THERAPY AND COUNTRY
    • FIGURE 19 JAPAN DOMINATES THE APAC MARKET
  • 4.3 PEN NEEDLES MARKET: GEOGRAPHIC MIX
    • FIGURE 20 INDIA & CHINA TO WITNESS THE HIGHEST GROWTH IN THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing prevalence of chronic diseases
    • FIGURE 22 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN THE US, 1995-2030 (MILLION INDIVIDUALS)
    • FIGURE 23 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040
      • 5.2.1.2 Favorable reimbursement in select countries
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Preference for alternative modes of drug delivery
      • 5.2.2.2 Poor reimbursement scenario in developing countries
      • 5.2.2.3 Needle anxiety
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing preference for biosimilar drugs
      • 5.2.3.2 Emerging markets
    • TABLE 2 RISING INCOME LEVELS IN EMERGING COUNTRIES
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Reuse of pen needles
      • 5.2.4.2 Misuse of injection pens
  • 5.3 PRICING ANALYSIS
    • TABLE 3 PRICING OF PEN NEEDLES AVAILABLE IN THE MARKET
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 24 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM MARKET MAP
    • FIGURE 25 PEN NEEDLES MARKET: ECOSYSTEM MARKET MAP
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 PEN NEEDLES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.6.2 BARGAINING POWER OF SUPPLIERS
    • 5.6.3 BARGAINING POWER OF BUYERS
    • 5.6.4 THREAT OF SUBSTITUTES
    • 5.6.5 THREAT OF NEW ENTRANTS
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 26 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 NORTH AMERICA
      • 5.8.1.1 US
    • TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.8.1.2 Canada
    • TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 27 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS
    • 5.8.2 EUROPE
    • FIGURE 28 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES
    • 5.8.3 ASIA PACIFIC
      • 5.8.3.1 Japan
    • TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.8.3.2 China
    • TABLE 9 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL
    • TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.8.3.3 India
  • 5.9 IMPACT OF COVID-19 ON THE PEN NEEDLES MARKET
  • 5.10 PATENT ANALYSIS
    • 5.10.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES
    • FIGURE 29 PATENT PUBLICATION TRENDS (2011-MAY 2021)
    • 5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLES PATENTS (JANUARY 2011-JUNE 2021)
    • FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR PEN NEEDLE PATENTS (JANUARY 2011-JUNE 2021)
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGY
      • 5.11.1.1 Fluid flow enhancement technology
    • 5.11.2 COMPLEMENTARY TECHNOLOGY
      • 5.11.2.1 Microfabricated needles
    • 5.11.3 ADJACENT TECHNOLOGY
      • 5.11.3.1 Autoinjectors

6 PEN NEEDLES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 11 PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 12 PEN NEEDLES MARKET, BY TYPE, 2019-2026 (MILLION UNITS)
  • 6.2 STANDARD PEN NEEDLES
    • 6.2.1 STANDARD PEN NEEDLES ARE PREFERRED OVER SAFETY PEN NEEDLES AS THEY ARE MORE AFFORDABLE
    • TABLE 13 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 14 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 15 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (MILLION UNITS)
  • 6.3 SAFETY PEN NEEDLES
    • 6.3.1 GROWING CONCERN OVER NEEDLESTICK INJURIES DRIVES THE GROWTH OF SAFETY PEN NEEDLES
    • TABLE 16 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 17 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 18 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (MILLION UNITS)

7 PEN NEEDLES MARKET, BY LENGTH

  • 7.1 INTRODUCTION
    • TABLE 19 PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
  • 7.2 8MM
    • 7.2.1 8MM PEN NEEDLES WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD
    • TABLE 20 8MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 21 8MM PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 5MM
    • 7.3.1 5MM PEN NEEDLES TO REGISTER SECOND-HIGHEST GROWTH RATE DURING THE STUDY PERIOD
    • TABLE 22 5MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 23 5MM PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 6MM
    • 7.4.1 6MM PEN NEEDLES ARE THE MOST COMMONLY USED NEEDLES ACROSS THE GLOBE
    • TABLE 24 6MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 25 6MM PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.5 4MM
    • 7.5.1 4MM PEN NEEDLES ARE EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
    • TABLE 26 4MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 27 4MM PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.6 12MM
    • 7.6.1 THE POPULARITY OF SHORTER & LESS PAINFUL NEEDLES HAMPERS THE GROWTH OF THE 12MM PEN NEEDLES MARKET
    • TABLE 28 12MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 29 12MM PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.7 10MM
    • 7.7.1 AVAILABILITY OF SHORTER PEN NEEDLES TO RESTRAIN THE GROWTH OF THE 10MM PEN NEEDLES MARKET
    • TABLE 30 10MM PEN NEEDLES OFFERED BY KEY PLAYERS
    • TABLE 31 10MM PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

8 PEN NEEDLES MARKET, BY THERAPY

  • 8.1 INTRODUCTION
    • TABLE 32 PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
  • 8.2 INSULIN THERAPY
    • 8.2.1 RISING PREVALENCE OF DIABETES DRIVES THE GROWTH OF THE PEN NEEDLES MARKET FOR INSULIN THERAPY
    • TABLE 33 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY
    • 8.3.1 STRONG FOCUS OF MAJOR PHARMACEUTICAL COMPANIES TO INTRODUCE GLP-1 DRUGS TO DRIVE MARKET GROWTH
    • TABLE 34 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 GROWTH HORMONE THERAPY
    • 8.4.1 DEVELOPMENT OF SUSTAINED-RELEASE GROWTH HORMONE FORMULATIONS FOR REDUCING INJECTION FREQUENCY TO RESTRAIN THE GROWTH OF THE PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY
    • TABLE 35 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.5 OTHER THERAPIES
    • TABLE 36 PEN NEEDLES MARKET FOR OTHER THERAPIES, BY COUNTRY, 2019-2026 (USD MILLION)

9 PEN NEEDLES MARKET, BY MODE OF PURCHASE

  • 9.1 INTRODUCTION
    • TABLE 37 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 9.2 RETAIL
    • 9.2.1 RETAIL PURCHASES OF PEN NEEDLES TO WITNESS HIGH GROWTH IN THE COMING YEARS OWING TO THE GROWING POPULARITY OF ONLINE PURCHASES
    • TABLE 38 PEN NEEDLES MARKET FOR RETAIL PURCHASES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 9.3 NON-RETAIL
    • 9.3.1 LARGE NUMBER OF NEEDLE-PHOBIC DIABETIC PATIENTS IS SUPPORTING THE GROWTH OF THIS SEGMENT
    • TABLE 39 INDICATIVE LIST OF REGULATIONS
    • TABLE 40 PEN NEEDLES MARKET FOR NON-RETAIL PURCHASES, BY COUNTRY, 2019-2026 (USD MILLION)

10 PEN NEEDLES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 41 PEN NEEDLES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • FIGURE 32 EMERGING COUNTRIES ARE EXPECTED TO WITNESS HIGHER GROWTH OVER THE FORECAST PERIOD
  • 10.2 NORTH AMERICA
    • FIGURE 33 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT
    • TABLE 42 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 43 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 44 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 45 NORTH AMERICA: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 46 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 The US dominates the global pen needles market
    • FIGURE 34 TOTAL FERTILITY RATE IN THE US POPULATION (1990-2020)
    • TABLE 47 US: KEY MACROINDICATORS
    • TABLE 48 US: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 49 US: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 50 US: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 51 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Unfavorable regulatory processes in Canada to restrain the market growth
    • TABLE 52 CANADA: KEY MACROINDICATORS
    • TABLE 53 CANADA: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 54 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 55 CANADA: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 56 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 57 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 58 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 59 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 60 EUROPE: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 61 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 High diabetes expenditure and reimbursement for pen needles is expected to drive the market in Germany
    • TABLE 62 GERMANY: KEY MACROINDICATORS
    • TABLE 63 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 64 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 65 GERMANY: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 66 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Favorable health insurance system to drive the pen needles market in France
    • TABLE 67 FRANCE: KEY MACROINDICATORS
    • TABLE 68 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 69 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 70 FRANCE: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 71 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 NHS support and access to cost-effective pen needles are likely to drive the market in the UK
    • TABLE 72 UK: KEY MACROINDICATORS
    • TABLE 73 UK: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 74 UK: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 75 UK: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 76 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Regional variation in terms of coverage and benefits to hinder the market growth
    • TABLE 77 ITALY: KEY MACROINDICATORS
    • TABLE 78 ITALY: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 79 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 80 ITALY: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 81 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Supportive regulations mandating the use of safety pen needles to boost the growth of the Spanish market
    • TABLE 82 SPAIN: KEY MACROINDICATORS
    • TABLE 83 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 85 SPAIN: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 86 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 87 ROE: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 ROE: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 89 ROE: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 90 ROE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 35 APAC: PEN NEEDLES MARKET SNAPSHOT
    • TABLE 91 APAC: PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 92 APAC: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 93 APAC: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 94 APAC: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 95 APAC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 High diabetes incidence and supportive reimbursement policies to drive the market growth in Japan
    • TABLE 96 JAPAN: KEY MACROINDICATORS
    • TABLE 97 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 99 JAPAN: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 100 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Large patient population and healthcare infrastructure improvements to drive the market growth in China
    • TABLE 101 CHINA: KEY MACROINDICATORS
    • TABLE 102 CHINA: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 103 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 104 CHINA: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 105 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.4.3 AUSTRALIA AND NEW ZEALAND
      • 10.4.3.1 Growing geriatric population in Australia and New Zealand to drive the pen needles market
    • TABLE 106 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 107 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 108 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 109 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Healthcare infrastructural improvements and implementation of favorable government initiatives support the market in India
    • TABLE 110 INDIA: KEY MACROINDICATORS
    • TABLE 111 INDIA: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 113 INDIA: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 114 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Growing chronic diseases in the geriatric population augments the growth of the pen needles market
    • TABLE 115 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 117 SOUTH KOREA: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 118 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.4.6 SOUTHEAST ASIA
      • 10.4.6.1 Growing awareness about diabetes drives the pen needles market
    • FIGURE 36 GROWING PREVALENCE OF DIABETES IN SOUTHEAST ASIA
    • FIGURE 37 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018)
    • FIGURE 38 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION)
    • TABLE 119 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 120 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 121 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 122 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.4.7 REST OF APAC
    • TABLE 123 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 ROAPAC: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 125 ROAPAC: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 126 ROAPAC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 127 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 128 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 130 LATIN AMERICA: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 131 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil dominates the pen needles market in Latin America
    • TABLE 132 BRAZIL: KEY MACROINDICATORS
    • TABLE 133 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 134 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 135 BRAZIL: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 136 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Increasing incidence of lifestyle-related disorders and rising awareness drive market growth in Mexico
    • TABLE 137 MEXICO: KEY MACROINDICATORS
    • TABLE 138 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 140 MEXICO: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 141 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • FIGURE 39 HEALTH EXPENDITURE IN LATIN AMERICAN COUNTRIES IN 2018 (% GDP)
    • TABLE 142 ROLA: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 ROLA: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 144 ROLA: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 145 ROLA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST AND AFRICA
    • 10.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY MAY SUPPORT MARKET GROWTH
    • TABLE 146 MEA: PEN NEEDLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 147 MEA: PEN NEEDLES MARKET, BY LENGTH, 2019-2026 (USD MILLION)
    • TABLE 148 MEA: PEN NEEDLES MARKET, BY THERAPY, 2019-2026 (USD MILLION)
    • TABLE 149 MEA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES
  • 11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PEN NEEDLES MARKET
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 41 PEN NEEDLES MARKET SHARE, BY KEY PLAYER, 2020
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 42 PEN NEEDLES MARKET: COMPANY EVALUATION QUADRANT (2020)
  • 11.6 COMPANY EVALUATION QUADRANT FOR START-UPS
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 DYNAMIC COMPANIES
    • 11.6.3 STARTING BLOCKS
    • 11.6.4 RESPONSIVE COMPANIES
    • FIGURE 43 PEN NEEDLES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)
  • 11.7 COMPANY PRODUCT FOOTPRINT
    • TABLE 150 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET
    • TABLE 151 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET, BY LENGTH
    • TABLE 152 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET, BY THERAPY
  • 11.8 COMPANY GEOGRAPHIC FOOTPRINT
    • TABLE 153 GEOGRAPHIC REVENUE MIX: PEN NEEDLES MARKET (2020)
  • 11.9 COMPETITIVE INTENSITY
    • 11.9.1 EVALUATION PARAMETERS
    • TABLE 154 EVALUATION PARAMETERS & SCORES
    • 11.9.2 SCORING METHODOLOGY FOR COMPETITIVE INTENSITY
    • FIGURE 44 SCORING METHODOLOGY FOR COMPETITIVE INTENSITY
    • 11.9.3 COMPETITIVE INTENSITY SCORE, BY COMPANY
      • 11.9.3.1 Competitive intensity score for BD
    • TABLE 155 COMPETITIVE INTENSITY FOR BD
      • 11.9.3.2 Competitive intensity score for Novo Nordisk
    • TABLE 156 COMPETITIVE INTENSITY FOR NOVO NORDISK
      • 11.9.3.3 Competitive intensity score for Ypsomed
    • TABLE 157 COMPETITIVE INTENSITY FOR YPSOMED
    • 11.9.4 COMPETITIVE INTENSITY MAPPING: BD, NOVO NORDISK, AND YPSOMED
    • FIGURE 45 COMPARISONS OF COMPETITIVE INTENSITY SCORES: BD, NOVO NORDISK, AND YPSOMED
    • FIGURE 46 RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND PEN NEEDLE FOCUS
      • 11.9.4.1 Product launches/technological advancements
    • FIGURE 47 BD HAS A HIGHER FOCUS ON INNOVATION FOR ITS PEN NEEDLES BUSINESS
      • 11.9.4.2 Promotional/marketing activities
    • FIGURE 48 BD AND NOVO NORDISK SHOWCASE A HIGH FOCUS ON MARKETING & PROMOTIONAL ACTIVITIES
      • 11.9.4.3 Sponsorships/donations/education/awareness campaigns
    • FIGURE 49 NOVO NORDISK A/S HAS A HIGH FOCUS ON DIABETES EDUCATION & AWARENESS
      • 11.9.4.4 Certifications/accreditations/awards
    • FIGURE 50 BD, NOVO NORDISK, AND YPSOMED EQUALLY EXHIBIT HIGH COMPLIANCE WITH INDUSTRY STANDARDS
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 PRODUCT LAUNCHES
    • TABLE 158 PRODUCT LAUNCHES (JANUARY 2018 - JUNE 2021)
    • 11.10.2 DEALS
    • TABLE 159 DEALS (JANUARY 2018- JUNE 2021)
    • 11.10.3 OTHER DEVELOPMENTS
    • TABLE 160 OTHER DEVELOPMENTS (JANUARY 2018- JUNE 2021)

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business overview, Products offered, Recent developments, MNM view)**
    • 12.1.1 BECTON, DICKINSON AND COMPANY
    • TABLE 161 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 51 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • 12.1.2 NOVO NORDISK A/S
    • TABLE 162 NOVO NORDISK A/S: BUSINESS OVERVIEW
    • FIGURE 52 NOVO NORDISK A/S: COMPANY SNAPSHOT (2020)
    • 12.1.3 YPSOMED HOLDING AG
    • TABLE 163 YPSOMED HOLDING AG: BUSINESS OVERVIEW
    • FIGURE 53 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2020)
    • 12.1.4 B. BRAUN MELSUNGEN AG
    • TABLE 164 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
    • FIGURE 54 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
    • 12.1.5 TERUMO CORPORATION
    • TABLE 165 TERUMO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 55 TERUMO CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.6 NIPRO CORPORATION
    • TABLE 166 NIPRO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 56 NIPRO CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.7 OWEN MUMFORD
    • TABLE 167 OWEN MUMFORD: BUSINESS OVERVIEW
    • 12.1.8 ARKRAY
    • TABLE 168 ARKRAY: BUSINESS OVERVIEW
    • 12.1.9 ULTIMED
    • TABLE 169 ULTIMED: BUSINESS OVERVIEW
    • 12.1.10 HINDUSTAN SYRINGES AND MEDICAL DEVICES
    • TABLE 170 HINDUSTAN SYRINGES AND MEDICAL DEVICES: BUSINESS OVERVIEW
    • 12.1.11 MONTMED
    • TABLE 171 MONTMED: BUSINESS OVERVIEW
    • 12.1.12 HTL-STREFA
    • TABLE 172 HTL-STREFA: BUSINESS OVERVIEW
    • 12.1.13 ALLISON MEDICAL, INC.
    • TABLE 173 ALLISON MEDICAL: BUSINESS OVERVIEW
    • 12.1.14 GLUCORX
    • TABLE 174 GLUCORX: BUSINESS OVERVIEW
    • 12.1.15 BERPU MEDICAL TECHNOLOGY
    • TABLE 175 BERPU MEDICAL TECHNOLOGY: BUSINESS OVERVIEW
    • 12.1.16 ADVACARE PHARMA
    • TABLE 176 ADVACARE PHARMA: BUSINESS OVERVIEW
    • 12.1.17 ARTSANA GROUP
    • TABLE 177 ARTSANA GROUP: BUSINESS OVERVIEW
    • 12.1.18 PROMISEMED DIABETES CARE
    • TABLE 178 PROMISEMED DIABETES CARE: BUSINESS OVERVIEW
    • 12.1.19 TRIVIDIA HEALTH
    • TABLE 179 TRIVIDIA HEALTH: BUSINESS OVERVIEW
    • 12.1.20 VOGT MEDICAL VERTRIEB
    • TABLE 180 VOGT MEDICAL VERTRIEB GMBH: BUSINESS OVERVIEW
  • *Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 VAN HEEK MEDICAL
    • TABLE 181 VAN HEEK MEDICAL: COMPANY OVERVIEW
    • 12.2.2 SIMPLE DIAGNOSTICS
    • TABLE 182 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW
    • 12.2.3 IYON
    • TABLE 183 IYON: COMPANY OVERVIEW
    • 12.2.4 LINKS MEDICAL PRODUCTS
    • TABLE 184 LINKS MEDICAL PRODUCTS: COMPANY OVERVIEW
    • 12.2.5 MHC MEDICAL PRODUCTS
    • TABLE 185 MHC MEDICAL PRODUCTS: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS